Nelarabine
Showing 1 - 25 of 32
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
- BL-8040
- Nelarabine
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)
Recruiting
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Everolimus
- +3 more
-
Atlanta, Georgia
- +3 more
Aug 18, 2022
T-ALL, T-NHL (Lymphoblastic) Trial in Germany (Nelarabine)
Completed
- T-ALL, T-NHL (Lymphoblastic)
- Nelarabine
-
Stuttgart, Baden-Württemberg, Germany
- +10 more
Aug 16, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)
Active, not recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Pegaspargase
- +14 more
-
Boston, Massachusetts
- +8 more
Nov 10, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Leukemia Trial in Houston (Nelarabine)
Completed
- Leukemia
- Nelarabine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 10, 2020
Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma Trial in Worldwide (Nelarabine, Etoposide,
Terminated
- Relapsed T-Cell Acute Lymphoblastic Leukemia
- Relapsed T-Cell Lymphoblastic Lymphoma
- Nelarabine
- +4 more
-
Los Angeles, California
- +36 more
Sep 8, 2020
T-cell Adult Acute Lymphoblastic Leukemia Trial in Paris (nelarabine)
Recruiting
- T-cell Adult Acute Lymphoblastic Leukemia
- nelarabine
-
Paris, FranceHematology
Oct 18, 2019
Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- (no location specified)
Oct 24, 2023
NSCLC Trial in Iowa City ([18F]F-ARAG PET)
Not yet recruiting
- Non-small Cell Lung Cancer
- [18F]F-ARAG PET
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 10, 2023
Relapsed/Refractory Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Leukemia Trial in France
Recruiting
- Relapsed/Refractory Acute Lymphoblastic Leukemia
- T-cell Acute Lymphoblastic Leukemia
-
Amiens, France
- +30 more
Apr 14, 2023
Lung Cancer, Nonsmall Cell Trial in Sacramento ([18F]F-AraG Imaging)
Enrolling by invitation
- Lung Cancer, Nonsmall Cell
- [18F]F-AraG Imaging
-
Sacramento, CaliforniaUC Davis EXPLORER Molecular Imaging Center
Jan 4, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal
Terminated
- Acute Lymphoblastic Leukemia
- +3 more
- Dexamethasone
- +13 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 8, 2019
T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- Daratumumab / Hyaluronidase Injection
-
Chicago, IllinoisNorthwestern
Jun 17, 2022
ARRANON G (Nelarabine) Injection 250mg
Completed
- Cancer
- Nelarabine
-
Tsukuba, JapanUniversity of Tsukuba Hospital
Oct 30, 2017
Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic Trial in Aichi, Tokyo (Nelarabine injection 400mg/m2, Nelarabine
Completed
- Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic
- Nelarabine injection 400mg/m2
- +3 more
-
Aichi, Japan
- +2 more
Nov 8, 2017
Brain Function in Young Patients Receiving Methotrexate for
Completed
- Childhood B Acute Lymphoblastic Leukemia
- +6 more
- Cognitive Assessment
- +4 more
-
Birmingham, Alabama
- +111 more
Jul 19, 2017
Observational Study of Nelarabine in Children and Young Adults
Completed
- Leukaemia, Lymphoblastic, Acute
- nelarabine
-
Aahur N, Denmark
- +30 more
Jan 12, 2015
Leukemia Trial in United States (nelarabine)
Completed
- Leukemia
- nelarabine
-
Mobile, Alabama
- +106 more
Mar 5, 2015
Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute
Completed
- Recurrent Childhood Acute Lymphoblastic Leukemia
- +2 more
- nelarabine
- +3 more
-
Arcadia, CaliforniaChildren's Oncology Group
Jul 1, 2013